Therapeutic Activities and Phytochemistry of Physalis Species Based on Traditional and Modern Medicine

Document Type : Review


1 Department of Pharmacognosy, Faculty of Pharmacy, Mazandaran University of Medical Sciences, Sari, Iran.

2 Traditional and Complementary Medicine Research Center, Faculty of Medicine, Mazandaran University of Medical Sciences, Sari, Iran.


Physalis, the fifth largest genus of the Solanaceae family, consists many species which are used as food and natural remedies. Phytochemical investigations on Physalis species have led to characterization of important secondary metabolites such as withaphysalins, physalins and phytosterols which are responsible for wide range of pharmacological effects such as potent cytotoxic activity against various type of human cancer cell lines, immunomodulatory and cancer chemopreventive effects. Theyare widely used in the indigenous system of medicine for treatment of kidney and urinary disorders, leishmaniasis, inflammations, skin infections and etc. Based on Iranian traditional medicine texts, Physalis is effective for treatment of several disorders such as asthma, liver, kidney and bladder dysfunctions, wounds, hemorrhoids, and helminthic diseases. Based on recent surveys, many of the above properties have not been investigated so far except the for the healing effects on liver dysfunction. This review might be a starting point for the development of the new therapeutic applications and more investigations on Physalis species in the future.


Main Subjects

[1] Elpel T. Botany in a day: the patterns method of plant identification. Thomas J. Elpel’s herbal field guide to plant families of North America. 2nd ed. Pony: Hops Press, 2004.
[2] Medina-Medrano JR, Almaraz-Abarca N, González-Elizondo MS, Uribe-Soto JN, González-Valdez LS, Herrera-Arrieta Y. Phenolic constituents and antioxidant properties of five wild species of Physalis (Solanaceae). Bot Stud. 2015; 56(1): 19-24.
[3] Azadbakht M, Azadbakht M. Medicinal plants systematic according to APG. 2nd ed. Tehran: Arjmand, 2013.
[4] Sayadi S, Mehrabian A. Diversity and distribution patterns of Solanaceae in Iran: implications for conservation and habitat management with emphasis on endemism and diversity in SW Asia. Rastaniha. 2016; 4(2): 57-64.
[5] Mozaffarian V. Identification of medicinal and aromatic plants of Iran. Tehran: Arjmand, 2013.
[6] Oliveira SF, Gonçalves FJ, Correia PM, Guiné RP. Physical properties of Physalis peruviana L. Open Agric. 2016; 1(1): 56-62.
[7] Kindscher K, Long Q, Corbett S, Bosnak K, Loring H, Cohen M. The ethnobotany and ethnopharmacology of wild tomatillos, Physalis longifolia Nutt., and related Physalis species: a review. Econ Bot. 2012; 66(3): 298-310.
[8] Puente LA, Pinto-Muñoz CA, Castro ES, Cortés M. Physalis peruviana Linnaeus, the multiple properties of a highly functional fruit: a review. Food Res Int. 2011; 44(7): 33-40.
[9] Arenas P, Kamienkowski NM. Ethnobotany of the Genus Physalis L. (Solanaceae) in the South American Gran Chaco. Candollea. 2015; 63(1); 63-68.
[10] Von Mueller F. Select extra-tropical plants readily eligible for industrial culture or naturalization: with indications of their native countries and some of their uses. 8th ed. Melbourne: Troedel & Co, 2010.
[11] Patel PR, Gol NB, Rao TVR. Physiochemical changes in sunberry (Physalis minima L.) fruit during growth and ripening. Fruits. 2011; 66(1): 37-46.
[12] Aghili Khorasani MH. Makhzan al advieh. Tehran: Rah-e-kamal press, 2001.
[13] Sharafkandi A. The Canon of medicine. Tehran: Soroush Publications, 1987.
[14] Ansari A. Ekhtiarate Badiei. Tehran: Pakhshe Razi, 1992.
[15] Bakhshi Jouybari H, Hosseini AS, Davoodi A, Mirzaee F, Azadbakht M. Materia medica used in jaundice based on Persian medicine. Res J Pharmacogn. 2018; 5(4): 83-93.
[16] Mirzaee F, Hosseini A, Jouybari HB, Davoodi A, Azadbakht M. Medicinal, biological and phytochemical properties of Gentiana species. J Tradit Complement Med. 2017; 34(2); 89-96.
[17] Damu AGKuo PCSu CRKuo THChen THBastow KFLee KHWu TS. Isolation, structures, and structure- cytotoxic activity relationships of withanolides and physalins from Physalis angulata. J Nat Prod. 2007; 70(7): 46-52.
[18] Bastos GNSantos ARFerreira VMCosta AMBispo CISilveira AJDo Nascimento JL. Antinociceptive effect of the aqueous extract obtained from roots of Physalis angulata L. on mice. J Ethnopharmacol. 2006; 103(2): 21-35.
[19] Al-Olayan EM, El-Khadragy MF, Aref AM, Othman MS, Kassab RB, Abdel Moneim AE. The potential protective effect of Physalis peruviana L. against carbon tetrachloride-induced hepatotoxicity in rats is mediated by suppression of oxidative stress and downregulation of MMP-9 expression. Oxid Med Cell Longev. 2014; 9(3); 78-96.
[20] Naseri MKG, Mohammadian M, Naseri ZG. Antispasmodic effect of Physalis alkekengi fruit extract on rat uterus. Int J Reprod Med. 2008; 6(4): 62-68.
[21] Mahalakshmi A, Nidavani RB. Physalis angulata L.: an ethanopharmacological review. Indo Am J Pharm. 2014; 8(5): 65-78.
[22] Zarei A, Shariati M, Rasekh F. The effect of Physalis alkekengi extract on the physiologic function of organ tissues: a mini-review. Arak Med Univ J. 2012; 15(66): 94-104.
[23] Nathiya M, Dorcus D. Preliminary phytochemical and antibacterial studies on Physalis minima Linn. Int J Curr Sci. 2012; 4(1): 30-34.
[24] Pardo JM, Fontanilla MR, Ospina LF, Espinosa L. Determining the pharmacological activity of Physalis peruviana fruit juice on rabbit eyes and fibroblast primary cultures. Invest Ophthalmol Vis Sci. 2008; 49(7): 9-26.
[25] Adonizio AL. Anti-quorum sensing agents from South Florida medicinal plants and their attenuation of Pseudomonas aeruginosa pathogenicity. PhD Theses. Florida International University, Florida, USA, 2008.
[26] Alrashedy NA, Molina J. The ethnobotany of psychoactive plant use: a phylogenetic perspective. Peer J. 2016; 4(1): 45-63.
[27] Rodrigues E. Plants and animals utilized as medicines in the Jaú National Park (JNP), Brazilian Amazon. Phytother Res. 2006; 20(5): 78-91.
[28] Jovel EM, Cabanillas J, Towers G. An ethnobotanical study of the traditional medicine of the Mestizo people of Suni Mirano, Loreto, Peru. J Ethnopharmacol. 1996; 53(3): 49-56.
[29] Acharya E, Pokhrel B. Ethno-medicinal plants used by Bantar of Bhaudaha, Morang, Nepal. Our Nature. 2006; 4(1): 96-103.
[30] Jarić SPopović ZMacukanović-Jocić MDjurdjević LMijatović MKaradzić BMitrović MPavlović P. An ethnobotanical study on the usage of wild medicinal herbs from Kopaonik Mountain (Central Serbia). J Ethnopharmacol. 2007; 111(1): 60-75.
[31] Njoroge G, Bussmann R, Gemmill B, Newton LE, Ngumi V. Utilisation of weed species as sources of traditional medicines in central Kenya. Lyonia. 2004; 7(2): 71-87.
[32] Jiofack T, Fokunang C, Guedje N, Kemeuze V. Ethnobotany and phytomedicine of the upper Nyong valley forest in Cameroon.  Afr J Pharm Pharmacol. 2009; 3(4): 44-50.
[33] Abubakar M, Musa A, Ahmed A, Hussaini I. The perception and practice of traditional medicine in the treatment of cancers and inflammations by the Hausa and Fulani tribes of Northern Nigeria. J Ethnopharmacol. 2007; 111(3): 9-25.
[34] Odugbemi TO, Akinsulire OR, Aibinu IE, Fabeku PO. Medicinal plants useful for malaria therapy in Okeigbo, Ondo State, Southwest Nigeria. Afr J Tradit Complement Altern Med. 2007; 4(2): 8-19.
[35] Parkash V, Aggarwal A. Traditional uses of ethnomedicinal plants of lower foot-hills of Himachal Pradesh-I. Indian J Tradit Know. 2010; 9(3): 519-521.
[36] Vanila D, Ghanthikumar S, Manickam V. Ethnomedicinal uses of plants in the plains area of the Tirunelveli-District, Tamilnanu, India. Ethnobot Leaflets. 2008; 8(1): 63-82.
[37] Rajakaruna N, Harris CS, Towers G. Antimicrobial activity of plants collected from serpentine outcrops in Sri Lanka. Pharm Biol. 2002; 40(3): 35-44.
[38] Zakaria M. Traditional Malay medicinal plants. 1th ed. Kuala lumpur: Institut Terjemahn Negara, 2010.
[39] Jain S, Srivastava S. Traditional uses of some Indian plants among islanders of the Indian Ocean. Indian J Tradit Know. 2005; 8(2): 56-78.
[40] Hasan SA, Uddin MM, Huda KN, Das A, Tabassum N, Hossain MR, Rahmatuallah M. Ethnomedicinal plants of two village folk medicinal practitioners in Rajshahi district, Bangladesh: comparison of their folk medicinal uses with Ayurvedic uses. Am Eurasian J Sustain Agric.  2014; 8(3): 9-10.
[41] Anisuzzaman M, Rahman A, Harun-Or-Rashid M, Naderuzzaman A, Islam A. An ethnobotanical study of Madhupur, Tangail. J Appl Sci Res. 2007; 3(7): 19-30.
[42] Rahman A, Kabir E, Sima S, Sultana R, Nasiruddin M, Naderuzzaman A. Study of an ethnobotany at the village Dohanagar, Naogaon. J Appl Sci Res. 2010; 6(9): 66-73.
[43] Balangcod TD, Balangcod AKD. Ethnomedical knowledge of plants and healthcare practices among the Kalanguya tribe in Tinoc, Ifugao, Luzon, Philippines. Indian J Tradit Know. 2011; 7(1): 34-54.
[44] Lee C, Houghton P. Cytotoxicity of plants from Malaysia and Thailand used traditionally to treat cancer. J Ethnopharmacol. 2005; 100(3): 37-43.
[45] Helvacı S, Kökdil G, Kawai M, Duran N, Duran G, Güvenç A. Antimicrobial activity of the extracts and physalin D from Physalis alkekengi and evaluation of antioxidant potential of physalin D. Pharm Biol. 2010; 48(2): 42-50.
[46] He QP, Ma L, Luo JY, He FY, Lou LG, Hu LH. Cytotoxic withanolides from Physalis angulata L. Nat Prod Res. 2007; 4(3): 43-56.
[47] Tong H, Liang Z, Wang G. Structural characterization and hypoglycemic activity of a polysaccharide isolated from the fruit of Physalis alkekengi L. Carbohydr Polym. 2008; 71(2): 16-23.
[48] Wasim A, Khan N, Ghufran A, Shamshad A. Physico-chemical standardization of seeds of Kaknaj (Physalis alkekengi Linn.). Hamdard Med. 2010; 53(3): 77-82.
[49] Ballabh B, Chaurasia O, Ahmed Z, Singh SB. Traditional medicinal plants of cold desert Ladakh-used against kidney and urinary disorders. J Ethnopharmacol. 2008; 118(2): 331-442.
[50] Amini A. Dictionary of therapeutic plants. Tehran: Tehran University Press, 2004.
[51] Zargari A. Medicinal plants. 3th ed. Tehran: Tehran University Press, 1992.
[52] Amiri MS, Joharchi MR, TaghavizadehYazdi ME. Ethno-medicinal plants used to cure jaundice by traditional healers of Mashhad, Iran. Iran J Pharm Res. 2014; 13(1): 157-189.
[53] Moein M, Zarshenas MM, Khademian S, Razavi AD. Ethnopharmacological review of plants traditionally used in Darab (south of Iran). Trends Pharm Sci. 2015; 1(1): 39-43.
[54] Bahmani M, Nejad ASM, Shah NA, Shah SA, Rafieian-Kopaei M, Mahmoodnia L. Survey on ethnobotanical uses of anti-cancer herbs in southern region of Ilam, west Iran. J Biol Res. 2017; 90(1): 34-65.
[55] Tonekaboni SM. Tohfat-ol-momenin. Tehran: Shahr Publication, 2008.
[56] Jorjani L. Zakhireh kharazmshahi. Tehran:  Bonyade Farhang Iran, 1992.
[57] Hassan HA, Serag HM, Qadir MS, Ramadan MF. Cape gooseberry (Physalis peruviana) juice as a modulator agent for hepatocellular carcinoma-linked apoptosis and cell cycle arrest. Biomed Pharmacother. 2017; 94(4): 29-37.
[58] Zavala D, Mauricio Q, Pelayo A, Posso M, Rojas J, Wolach V. Cytotoxic effect of Physalis peruviana (capuli) in colon cancer and chronic myeloid leukemia. An Fac Med Lima. 2006; 8(1): 67-78.
[59] Wu SJ, Ng LT, Lin DL, Huang SN, Wang SS, Lin CC. Physalis peruviana extract induces apoptosis in human Hep G2 cells through CD95/CD95L system and the mitochondrial signaling transduction pathway. Cancer Lett. 2004; 215(2): 199-208.
[60] Yen CY, Chiu CC, Chang FR, Chen JYF, Hwang CC, Hseu YC, Chang UC, Wu YC. 4β-Hydroxywithanolide E from Physalis peruviana (golden berry) inhibits growth of human lung cancer cells through DNA damage, apoptosis and G 2/M arrest. BMC Cancer. 2010; 10(1): 45-76.
[61] Chiang HC, Jaw S, Chen C, Kan W. Antitumor agent, physalin F from Physalis angulata L. Anticancer Res. 1991; 12(3): 43-57.
[62] Sun L, Liu J, Liu P, Yu Y, Ma L, Hu L. Immunosuppression effect of withangulatin A from Physalis angulata via heme oxygenase 1-dependent pathways. Process Biochem. 2011; 46(2): 82-95.
[63] Moneim AA, El-Deib KM. The possible protective effects of Physalis peruviana on carbon tetrachloride-induced nephrotoxicity in male albino rats. Life Sci J. 2012; 9(3): 38-52.
[64] Soares MBBrustolim DSantos LABellintani MCPaiva FPRibeiro YMTomassini TCRibeiro Dos Santos R. Physalins B, F and G, seco-steroids purified from Physalis angulata L., inhibit lymphocyte function and allogeneic transplant rejection. Int Immunopharmacol. 2006; 6(3): 48-76.
[65] Soares MB, Bellintani MC, Ribeiro IM, Tomassini TC, dos Santos RR. Inhibition of macrophage activation and lipopolysaccaride-induced death by seco-steroids purified from Physalis angulata L. Eur J Pharmacol. 2003; 459(1): 78-93.
[66] Zhang YJDG, Xu XR, Wu S, Li S, Li HB. Chemical components and bioactivities of Cape gooseberry (Physalis peruviana). Int J Food Saf Nutr Publ Health.2013; 3(1): 15-24.
[67] Bastos G, Silveira A, Salgado C, Picanço-Diniz D, Do Nascimento J. Physalis angulata extract exerts anti-inflammatory effects in rats by inhibiting different pathways. J Ethnopharmacol. 2008; 118(2): 46-51.
[68] Qiu LZhao FJiang ZHChen LXZhao QLiu HXYao XSQiu F. Steroids and flavonoids from Physalis alkekengi var. franchetii and their inhibitory effects on nitric oxide production. J Nat Prod. 2008; 4(1): 78-98.
[69] Martínez W, Ospina LF, Granados D, Delgado G. In vitro studies on the relationship between the anti-inflammatory activity of Physalis peruviana extracts and the phagocytic process. Immunopharmacol Immunotoxicol. 2010; 32(1): 63-73.
[70] Ramadan MF, Hassan NA, Elsanhoty RM, Sitohy MZ. Goldenberry (Physalis peruviana) juice rich in health‐beneficial compounds suppresses high‐cholesterol diet‐induced hypercholesterolemia in rats. J Food Biochem. 2013; 37(6): 34-54.
[71] Cobaleda-Velasco M, Alanis-Bañuelos RE, Almaraz-Abarca N, Rojas-López M, González-Valdez LS, Ávila-Reyes JA, Almares N, Rodrigo S. Phenolic profiles and antioxidant properties of Physalis angulata L. as quality indicators. J Pharm Pharmacog Res. 2017; 5(2): 114-123.
[72] Wasan KM, Najafi S, Wong J, Kwong M, Pritchard PH. Assessing plasma lipid levels, body weight, and hepatic and renal toxicity following chronic oral administration of a water soluble phytostanol compound, FM-VP4, to gerbils. J Pharm Pharm Sci. 2001; 4(3): 28-34.
[73] Jones PJ, Ntanios FY, Raeini-Sarjaz M, Vanstone CA. Cholesterol-lowering efficacy of a sitostanol-containing phytosterol mixture with a prudent diet in hyperlipidemic men. Am J Clin Nutr. 1999; 69(4): 1144-1150.
[74] Junior LDA, Quaglio AEV, de Almeida Costa CAR, Stasi LC. Intestinal anti-inflammatory activity of ground cherry (Physalis angulata L.) standardized CO2 phytopharmaceutical preparation. World J Gastroenterol.2017; 23(24): 43-69.
[75] Kumar S, Raju S, Harani A, David B, Rao K, Otilia B. Alpha-glucosidase inhibitory and hypoglycemic activities of Physalis minima extract. J Phcog. 2009; 1(4): 273-278.
[76] Sathyadevi M, Suchithra E, Subramanian S. Physalis peruviana Linn. fruit extract improves insulin sensitivity and ameliorates hyperglycemia in high-fat diet low dose STZ-induced type 2 diabetic rats. J Pharm Res. 2014; 8(4): 25-32.
[77] Rodríguez Ulloa SL, Rodríguez Ulloa EM. Efecto de la ingesta de Physalis peruviana (aguaymanto) sobre la glicemia postprandial en adultos jóvenes. Rev Med Vallejiana. 2007; 4(1): 43-53.
[78] Hassan AI, Ghoneim MA. A possible inhibitory effect of Physalis (Physalis pubescens L.) on diabetes in male rats. World Appl Sci J. 2013; 21(5): 670-681.
[79] Shu ZXing NWang QLi XXu BLi ZKuang H. Antibacterial and anti-inflammatory activities of Physalis alkekengi var. franchetii and its main constituents. Evid Based Complement Altern Med. 2016; 45(4): 98-123.
[80] Bahmani M, Rafieian-Kopaei M, Naghdi N, Nejad ASM, Afsordeh O. Physalis alkekengi: a review of its therapeutic effects. Curr Pharm Biotechnol. 2016; 9(3): 85-97.
[81] Abe F, Nagafuji S, Okawa M, Kinjo J. Trypanocidal constituents in plants minor withanolides from the aerial parts of Physalis angulata. Chem Pharm Bull. 2006; 54(8): 122-134.
[82] Cirigliano A, Colamarino I, Mareggiani G, Bado S. Biological effects of Physalis peruviana L. (Solanaceae) crude extracts and its major withanolides on Ceratitis capitata Wiedemann (Diptera tephritidae). Bol San Veg Plagas. 2008; 34(5): 15-37.
[83] Choudhary MI, Yousaf S, Ahmed S, Yasmeen K. Antileishmanial physalins from Physalis minima. Chem Biodivers. 2005; 2(9): 74-116.
[84] Kawai M, Matsuura T, Kyuno S, Matsuki H, Takenaka M, Katsuoka T, Saito K, Butsugan Y. A new physalin from Physalis alkekengi: structure of physalin L. Phytochemistry. 1987; 26(12): 34-65.
[85] Row LR, Reddy KS, Sarma NS, Matsuura T, Nakashima R. New physalins from Physalis angulata and Physalis lancifolia. structure and reactions of physalins D, I, G and K. Phytochemistry. 1980; 19(6): 81-117.
[86] Glotter E, Kirson I, Abraham A, Sethi PD, Subramanian SS. Steroidal constituents of Physalis minima (Solanaceae). J Chem Soc Perkin.1975; 14(2): 134-145.
[87] Kuo PCKuo THDamu AGSu CRLee EJWu TSShu RChen CMBastow KFChen THLee KH. Physanolide A, a novel skeleton steroid, and other cytotoxic principles from Physalis angulata. Org Lett. 2006; 8(14): 2953-2956.
[88] Sen G, Pathak H. Physalin L. A 13, 14-seco-16, 24 cyclosteroid from Physalis minima. Phytochemistry. 1995; 39(5): 87-95.
[89] Kawai MYamamoto TMakino BYamamura HAraki SButsugan YSaito K. The structure of physalin T from Physalis alkekengi var. francheti. J Asian Nat Prod Res. 2001; 3(3): 199-205.
[90] Sakurai K, Kobayashi S, Iwao T. Isolation of 4β-Hydroxywithanolide E, a new withanolide from Physalis peruviana L. Chem Pharm Bull (Tokyo). 1976; 24(6): 56-76.
[91] Chen LX, He H, Qiu F. Natural withanolides: an overview. Nat Prod Reports. 2011; 28(4): 40-705.
[92] Ray AB, Gupta M. Withastroids, a growing group of naturally occurring steroidal lactones.  Withastroids, a growing group of naturally occurring steroidal lactons. Fortschr Chem Org Naturst. 1994; 63(1): 101-106.
[93] Shingu K, Yahara S, Nohara T, Okabe H. Three new withanolides, physagulins A, B and D from Physalis angulata L. Chem Pharm Bull. 1992; 40(8): 91-102.
[94] Shingu K, Marubayashi N, Ueda I. Physagulin C, a new withanolide from Physalis angulata L. Chem Pharm Bull. 1991; 39(6): 37-95.
[95] Nagafuji S, Okabe H, Akahane H, Abe F. Trypanocidal constituents in plants 4. withanolides from the aerial parts of Physalis angulata. Biol Pharm Bull. 2004; 27(2): 99-121.